Results 91 to 100 of about 1,026 (172)

Health Disparities in Hepatitis D Virus Management: A Case Series on Improving Patient Access to Bulevirtide Therapy. [PDF]

Gastro Hep Adv
Elsharkawy A, Horobin L, Oakley R, Shah S.   +3 more
europepmc   +1 more source

Combination therapeutics for hepatitis delta virus infection: implications of the tobevibart-elebsiran SOLSTICE phase 2 trial. [PDF]

Transl Gastroenterol Hepatol
Block PD, Lim JK.
europepmc   +1 more source

Comparative Efficacy of Bulevirtide, Interferons, and Nucleos(t)ide Analogs for Chronic Hepatitis Delta: A Systematic Review and Network Meta-Analysis. [PDF]

Int J Hepatol
Karkra R, Mohsen M, Pagán-Busigó JE, Shamsian E, Bebawy M, Rella S, Tafesh Z, Gaglio P.   +7 more
europepmc   +1 more source

Resolution of Hepatitis Delta Virus-Related Cryoglobulinemic Vasculitis With the Use of Bulevirtide. [PDF]

ACG Case Rep J
Geremicca G, Labanca S, Pasta A, Pieri G, Marenco S, Cariati S, Grossi A, Giannini EG.   +7 more
europepmc   +1 more source

Ten-Year Outcomes in Liver Transplantation for HBV/HDV Coinfection: A Romanian Single-Center Cohort Study. [PDF]

J Clin Med
Iacob S, Chitul M, Brasoveanu V, Cerban R, Constantinescu I, Dorobantu B, Ester C, Gheorghe C, Ghioca M, Grasu M, Herlea V, Hrehoret D, Iacob R, Lupescu I, Matei E, Popescu I, Gheorghe L.   +16 more
europepmc   +1 more source

Hepatitis D in the Middle East: A Review of Disease Burden, Health-System Barriers, and Strategic Directions for Management and Elimination. [PDF]

Cureus
Alkhatry M, Alwan AJ, Qutub A, Alzanbagi A, Alzaabi F, Al Quraishi H, Al Mattooq M, Taha M, Altarrah MY, Alnahdi N, Al Marzooqi SH, Nabil Y, Aba-Alkhail F.   +12 more
europepmc   +1 more source

Frequency of CAP-Defined Hepatic Steatosis and Its Association with Liver Fibrosis in Patients with Hepatitis Delta. [PDF]

Viruses
Mermutluoğlu Ç, Dayan S, Demir Y, Mete AÖ, Çelen MK.   +4 more
europepmc   +1 more source

Impact of Double Reflex Testing and Linkage to Treatment on Clinical Outcomes of Chronic Hepatitis Delta Virus Infection in the United States. [PDF]

J Viral Hepat
Wong RJ, Gish RG, Jacobson IM, Lim JK, Rock M, Kinyik-Merena C, Ma H, Smith N, Kim C.   +8 more
europepmc   +1 more source

Safety and efficacy of libevitug in patients with chronic hepatitis B and D virus coinfection: A single-center, open-label, phase IIa trial in China. [PDF]

Hepatol Commun
Wang X, Chi X, Zhang Y, Kong F, Zhou X, Gu Y, Qi Y, Zou L, Zhou Z, Wen J, Chen P, Li G, Zhang Y, Ye B, Chen B, Sui J, Li W, Zhou H, Niu J.   +18 more
europepmc   +1 more source

Applying the COM-B Model to Identify Barriers to Bulevirtide Adherence in Chronic Hepatitis D: A Multicenter Italian Study. [PDF]

J Viral Hepat
Badia L, Ciancio A, Distefano M, Izzi A, Loglio A.   +4 more
europepmc   +1 more source